254 related articles for article (PubMed ID: 17583819)
1. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
Schadlu R; Kymes SM; Apte RS
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1667-72. PubMed ID: 17583819
[TBL] [Abstract][Full Text] [Related]
2. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
[TBL] [Abstract][Full Text] [Related]
3. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
4. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
5. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
Chaudhary V; Mao A; Hooper PL; Sheidow TG
Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
Retina; 2006; 26(6):602-12. PubMed ID: 16829800
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.
Singh CN; Saperstein DA
Retina; 2008 Jun; 28(6):789-93. PubMed ID: 18536593
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
Ruiz-Moreno JM; Montero JA; Zarbin MA
Retina; 2007; 27(4):458-61. PubMed ID: 17420698
[TBL] [Abstract][Full Text] [Related]
15. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
[TBL] [Abstract][Full Text] [Related]
16. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
[TBL] [Abstract][Full Text] [Related]
17. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D
Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.
Yip PP; Woo CF; Tang HH; Ho CK
Br J Ophthalmol; 2009 Jun; 93(6):754-8. PubMed ID: 19273471
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.
Iwama D; Otani A; Sasahara M; Yodoi Y; Gotoh N; Tamura H; Tsujikawa A; Yoshimura N
Br J Ophthalmol; 2008 Oct; 92(10):1352-6. PubMed ID: 18662914
[TBL] [Abstract][Full Text] [Related]
20. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
